CDKN2A and melanoma: Primary melanomas with BRAF V600E mutations indeed had more frequent inactivating mutations of the CDKN2A gene (45.2 vs. 27.7%, P = 0.027, Fisher's exact test), consistent with early corruption of critical cell-cycle checkpoint components triggered by OIS (Fig. 4A).